Vycor Medical (VYCO) Capital Expenditures (2010 - 2025)
Vycor Medical's (VYCO) quarterly Capital Expenditures came in at $1605.0 in Q4 2025, up 80350.0% year-on-year from N/an in Q4 2024, and up 160400.0% on a QoQ basis from $1.0 in Q3 2025.
Vycor Medical (VYCO) Capital Expenditures (2010 - 2025) Analysis & Trends
Vycor Medical (VYCO) has 16 years of Capital Expenditures data on file, last reported at $1605.0 in Q4 2025.
- On a quarterly basis, Capital Expenditures rose 80350.0% year-over-year to $1605.0 in Q4 2025; TTM through Dec 2025 was $7508.0, a 36.91% increase from a year earlier, with the FY2025 full-year figure at $5224.0, down 2.65% from the prior year.
- Capital Expenditures for Q4 2025 stood at $1605.0, up from $1.0 in the prior quarter.
- Over the last five years, Capital Expenditures for VYCO reached as high as $23935.0 in Q1 2021 and fell as low as -$322.0 in Q4 2022.
- Historically, Capital Expenditures has averaged $4546.5 across 5 years, with a median of $803.0 in 2025.
- Across the five-year window, Capital Expenditures tumbled 116.41% in 2021 and soared 80350.0% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at -$315.0 in 2021, then retreated by 2.22% to -$322.0 in 2022, then soared by 1933.54% to $5904.0 in 2023, then plunged by 100.03% to -$2.0 in 2024, then surged by 80350.0% to $1605.0 in 2025.
- Per Business Quant data, the three most recent Capital Expenditures figures were $1605.0 in Q4 2025, $1.0 in Q3 2025, and -$2.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 76.60 Mn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | -85.46 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,605.00 |
| Dec 31, 2025 | 1,605.00 |
| Sep 30, 2025 | 1.00 |
| Sep 30, 2025 | 1.00 |
| Dec 31, 2024 | -2.00 |
| Dec 31, 2024 | -2.00 |
| Dec 31, 2023 | 5,904.00 |
| Dec 31, 2023 | 5,904.00 |
| Dec 31, 2022 | -322.00 |
| Dec 31, 2022 | -322.00 |
| Sep 30, 2022 | -96.00 |
| Sep 30, 2022 | -96.00 |
| Dec 31, 2021 | -315.00 |
| Dec 31, 2021 | -315.00 |
| Sep 30, 2021 | 6,448.00 |
| Sep 30, 2021 | 6,448.00 |
| Jun 30, 2021 | 8,307.00 |
| Jun 30, 2021 | 8,307.00 |
| Mar 31, 2021 | 23,935.00 |
| Mar 31, 2021 | 23,935.00 |